documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
56 rows where agency_id = "FDA", document_type = "Rule" and posted_year = 2023 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-N-0582-0130 | FDA | FDA-2009-N-0582 | Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format Final Rule: Questions and Answers; Guidance for Industry; Small Entity Compliance Guide; Availability | Rule | Final Rule with Request for Comments | 2023-12-27T05:00:00Z | 2023 | 12 | 2023-12-27T05:00:00Z | 2023-12-27T14:34:36Z | 2023-28530 | 0 | 0 | 090000648635c371 | |
| FDA-2018-N-2727-0051 | FDA | FDA-2018-N-2727 | Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations | Rule | Direct Final Rule | 2023-12-21T05:00:00Z | 2023 | 12 | 2023-12-21T05:00:00Z | 2023-12-21T15:50:35Z | 2023-27935 | 0 | 0 | 090000648634dce5 | |
| FDA-2020-F-0151-0002 | FDA | FDA-2020-F-0151 | Food Additives Permitted in Feed and Drinking Water of Animals; Calcium Formate | Rule | Final Rule | 2023-12-19T05:00:00Z | 2023 | 12 | 2023-12-19T05:00:00Z | 2024-01-19T04:59:59Z | 2024-01-19T02:00:13Z | 2023-27857 | 0 | 0 | 0900006486346a65 |
| FDA-2019-N-4750-0040 | FDA | FDA-2019-N-4750 | Revocation of Uses of Partially Hydrogenated Oils in Foods; Confirmation of Effective Date | Rule | Direct Final Rule | 2023-12-14T05:00:00Z | 2023 | 12 | 2023-12-14T14:33:02Z | 2023-27506 | 0 | 0 | 0900006486339a44 | ||
| FDA-2023-N-0002-0031 | FDA | FDA-2023-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address | Rule | Final Rule | 2023-12-06T05:00:00Z | 2023 | 12 | 2023-12-06T05:00:00Z | 2024-05-06T12:04:48Z | 2023-26545 | 0 | 0 | 09000064862ff365 | |
| FDA-2023-D-4722-0001 | FDA | FDA-2023-D-4722 | Milk and Cream Products and Yogurt Products; Final Rule To Revoke the Standards for Lowfat Yogurt and Nonfat Yogurt and To Amend the Standard for Yogurt; Small Entity Compliance Guide; Availability | Rule | Direct Final Rule | 2023-11-28T05:00:00Z | 2023 | 11 | 2023-11-28T05:00:00Z | 2024-11-12T06:23:19Z | 2023-26095 | 1 | 0 | 09000064862bc465 | |
| FDA-2009-N-0582-0061 | FDA | FDA-2009-N-0582 | Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format | Rule | Direct Final Rule | 2023-11-21T05:00:00Z | 2023 | 11 | 2023-11-21T05:00:00Z | 2024-01-05T14:03:16Z | 2023-25428 | 0 | 0 | 090000648629f6eb | |
| FDA-2023-N-4487-0001 | FDA | FDA-2023-N-4487 | Medical Devices; Hematology and Pathology Devices; Classification of the Container System for the Processing and Storage of Red Blood Cell Components Reduced Oxygen Condition | Rule | Direct Final Rule | 2023-11-09T05:00:00Z | 2023 | 11 | 2023-11-09T05:00:00Z | 2023-11-09T14:55:24Z | 2023-24717 | 0 | 0 | 0900006486232116 | |
| FDA-2020-C-2131-0006 | FDA | FDA-2020-C-2131 | Listing of Color Additives Exempt From Certification; Jagua (Genipin-Glycine) Blue | Rule | Direct Final Rule | 2023-11-03T04:00:00Z | 2023 | 11 | 2023-11-03T04:00:00Z | 2023-12-05T04:59:59Z | 2023-12-02T02:01:28Z | 2023-24352 | 0 | 0 | 09000064861dfb35 |
| FDA-2022-D-0588-0012 | FDA | FDA-2022-D-0588 | Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements; Guidance for Industry; Availability. | Rule | Final Rule | 2023-10-18T04:00:00Z | 2023 | 10 | 2023-10-18T04:00:00Z | 2023-10-19T13:45:19Z | 2023-22957 | 0 | 0 | 090000648610438b | |
| FDA-2011-N-0179-0032 | FDA | FDA-2011-N-0179 | Prior Notice of Imported Food Questions and Answers (Edition 4): Guidance for Industry; Availability | Rule | Approval | 2023-10-13T04:00:00Z | 2023 | 10 | 2023-10-13T04:00:00Z | 2026-02-25T18:51:36Z | 2023-22649 | 0 | 0 | 09000064860cde7c | |
| FDA-2014-N-0053-1327 | FDA | FDA-2014-N-0053 | Requirements for Additional Traceability Records for Certain Foods; Technical Amendment | Rule | Final Rule | 2023-09-26T04:00:00Z | 2023 | 9 | 2023-09-26T04:00:00Z | 2023-09-26T14:20:20Z | 2023-20746 | 0 | 0 | 0900006485ff576c | |
| FDA-2023-N-3497-0001 | FDA | FDA-2023-N-3497 | Advisory Committee; Board of Tea Experts; Termination and Technical Amendment to the Citation for the Federal Advisory Committee Act | Rule | Final Rule | 2023-09-19T04:00:00Z | 2023 | 9 | 2023-09-19T04:00:00Z | 2023-09-19T17:00:30Z | 2023-20012 | 0 | 0 | 0900006485fcf75a | |
| FDA-2019-D-4212-0008 | FDA | FDA-2019-D-4212 | Wholesale Distributor Verification Requirement for Saleable Returned Drug Product and Dispenser Verification Requirements When Investigating a Suspect or Illegitimate Product—Compliance Policies, Revision 1; Guidance for Industry; Availability | Rule | Final Rule | 2023-09-01T04:00:00Z | 2023 | 9 | 2023-09-01T04:00:00Z | 2023-09-05T13:17:12Z | 2023-18899 | 0 | 0 | 0900006485f2ff32 | |
| FDA-2023-D-1909-0001 | FDA | FDA-2023-D-1909 | Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act—Compliance Policies; Guidance for Industry; Availability | Rule | Advance Notice of Proposed Rulemaking (ANPRM) | 2023-08-28T04:00:00Z | 2023 | 8 | 2023-08-28T14:19:12Z | 2023-18359 | 0 | 0 | 0900006485f00191 | ||
| FDA-2023-N-0002-0020 | FDA | FDA-2023-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications, Change of Sponsor, Change of Sponsor Address | Rule | Final Rule | 2023-08-16T04:00:00Z | 2023 | 8 | 2023-08-16T04:00:00Z | 2023-08-16T13:52:41Z | 2023-17454 | 0 | 0 | 0900006485e5693b | |
| FDA-2019-N-4750-0002 | FDA | FDA-2019-N-4750 | Revocation of Uses of Partially Hydrogenated Oils in Foods | Rule | Direct Final Rule | 2023-08-09T04:00:00Z | 2023 | 8 | 2023-08-09T04:00:00Z | 2023-10-24T03:59:59Z | 2023-10-24T01:03:03Z | 2023-16725 | 0 | 0 | 0900006485e047f1 |
| FDA-2023-N-0963-0001 | FDA | FDA-2023-N-0963 | Nomenclature Change for Dockets Management; Technical Amendment | Rule | Final Rule | 2023-07-14T04:00:00Z | 2023 | 7 | 2023-07-14T04:00:00Z | 2023-07-14T12:59:25Z | 2023-14716 | 0 | 0 | 0900006485cb1ad7 | |
| FDA-2022-N-2898-0002 | FDA | FDA-2022-N-2898 | Food Labeling, Infant Formula Requirements, Food Additives and Generally Recognized as Safe Substances, New Dietary Ingredient Notification; Technical Amendments; Correction | Rule | Correction | 2023-05-24T04:00:00Z | 2023 | 5 | 2023-05-24T04:00:00Z | 2023-05-24T13:02:04Z | 2023-10602 | 0 | 0 | 0900006485a42615 | |
| FDA-2023-D-1336-0001 | FDA | FDA-2023-D-1336 | Requirements for Additional Traceability Records for Certain Foods: What You Need To Know About the Food and Drug Administration Regulation: Guidance for Industry; Small Entity Compliance Guide; Availability | Rule | Final Rule with Request for Comments | 2023-05-19T04:00:00Z | 2023 | 5 | 2023-05-19T04:00:00Z | 2023-05-19T15:03:32Z | 2023-10666 | 0 | 0 | 0900006485a22b55 | |
| FDA-2000-P-0126-0135 | FDA | Revision of Yogurt Standards FDA-2000-P-0126 | International Dairy Foods Association: Response to the Objections and Requests for a Public Hearing on the Final Rule To Revoke the Standards for Lowfat Yogurt and Nonfat Yogurt and Amend the Standard for Yogurt; Correction | Rule | Correction | 2023-05-18T04:00:00Z | 2023 | 5 | 2023-05-18T04:00:00Z | 2023-05-19T12:32:00Z | 2023-10606 | 0 | 0 | 0900006485a1c5f8 | |
| FDA-2023-N-0002-0001 | FDA | FDA-2023-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications | Rule | Final Rule | 2023-05-03T04:00:00Z | 2023 | 5 | 2023-05-03T04:00:00Z | 2023-05-03T20:15:01Z | 2023-09212 | 0 | 0 | 09000064859c163d | |
| FDA-2000-P-0126-0132 | FDA | Revision of Yogurt Standards FDA-2000-P-0126 | International Dairy Foods Association: Response to the Objections and Requests for a Public Hearing on the Final Rule To Revoke the Standards for Lowfat Yogurt and Nonfat Yogurt and Amend the Standard for Yogurt | Rule | Final Rule | 2023-04-14T04:00:00Z | 2023 | 4 | 2023-04-14T04:00:00Z | 2023-05-16T03:59:59Z | 2023-05-19T12:31:03Z | 2023-07723 | 0 | 0 | 0900006485948f89 |
| FDA-2021-N-0310-0016 | FDA | FDA-2021-N-0310 | Medical Devices; Orthopedic Devices; Classification of Spinal Spheres for Use in Intervertebral Fusion Proceduress | Rule | Final Rule | 2023-03-30T04:00:00Z | 2023 | 3 | 2023-03-30T04:00:00Z | 2023-03-30T17:41:43Z | 2023-06566 | 0 | 0 | 090000648588ded2 | |
| FDA-2021-N-0310-0015 | FDA | FDA-2021-N-0310 | Medical Devices; Orthopedic Devices; Classification of Spinal Spheres for Use in Intervertebral Fusion Procedures | Rule | Final Rule | 2023-03-30T04:00:00Z | 2023 | 3 | 2023-03-30T04:00:00Z | 2023-04-10T14:30:06Z | 2023-06566 | 0 | 0 | 0900006485892feb | |
| FDA-2021-N-0309-0017 | FDA | FDA-2021-N-0309 | Effective Date of Requirement for Premarket Approval Applications for Spinal Spheres for Use in Intervertebral Fusion Procedure | Rule | Advance Notice of Proposed Rulemaking (ANPRM) | 2023-03-30T04:00:00Z | 2023 | 3 | 2023-03-30T04:00:00Z | 2023-03-30T17:12:14Z | 2023-06565 | 0 | 0 | 0900006485892ecc | |
| FDA-2023-N-0986-0001 | FDA | FDA-2023-N-0986 | Change of Address; Technical Amendment | Rule | Final Rule | 2023-03-27T04:00:00Z | 2023 | 3 | 2023-03-27T04:00:00Z | 2023-03-27T14:54:15Z | 2023-06260 | 0 | 0 | 090000648586903b | |
| FDA-2022-N-2898-0001 | FDA | FDA-2022-N-2898 | Food Labeling, Infant Formula Requirements, Food Additives and Generally Recognized as Safe Substances, New Dietary Ingredient Notification; Technical Amendments | Rule | Final Rule | 2023-03-24T04:00:00Z | 2023 | 3 | 2023-03-24T04:00:00Z | 2023-03-24T13:16:08Z | 2023-05418 | 0 | 0 | 0900006485840a4c | |
| FDA-2022-N-3262-0001 | FDA | FDA-2022-N-3262 | Definition of the Term ``Tobacco Product'' in Regulations Issued Under the Federal Food, Drug, and Cosmetic Act | Rule | Technical Amendment | 2023-03-24T04:00:00Z | 2023 | 3 | 2023-03-24T04:00:00Z | 2023-04-18T13:38:07Z | 2023-03950 | 0 | 0 | 09000064857fde1c | |
| FDA-2021-N-0246-0003 | FDA | FDA-2021-N-0246 | Medical Devices; Technical Amendments | Rule | Final Rule | 2023-03-21T04:00:00Z | 2023 | 3 | 2023-03-21T04:00:00Z | 2023-03-21T15:12:27Z | 2023-05657 | 0 | 0 | 090000648580f43d | |
| FDA-2022-N-0002-0050 | FDA | FDA-2022-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor | Rule | Final Rule | 2023-03-20T04:00:00Z | 2023 | 3 | 2023-03-20T04:00:00Z | 2023-03-20T13:29:00Z | 2023-05465 | 0 | 0 | 09000064857fdf5e | |
| FDA-2020-C-1309-0013 | FDA | FDA-2020-C-1309 | Listing of Color Additives Exempt From Certification; Spirulina Extract; Confirmation of Effective Date | Rule | Final Rule | 2023-03-16T04:00:00Z | 2023 | 3 | 2023-03-16T04:00:00Z | 2023-03-16T15:23:40Z | 2023-05361 | 0 | 0 | 09000064857b8ed7 | |
| FDA-2013-N-0134-0190 | FDA | FDA-2013-N-0134 | Mammography Quality Standards Act | Rule | Final Rule | 2023-03-10T05:00:00Z | 2023 | 3 | 2023-03-10T05:00:00Z | 2023-03-20T17:55:37Z | 2023-04550 | 0 | 0 | 090000648578c535 | |
| FDA-2022-N-0002-0039 | FDA | FDA-2022-N-0002 | New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Name and Address | Rule | Final Rule | 2023-03-10T05:00:00Z | 2023 | 3 | 2023-03-10T05:00:00Z | 2023-03-10T14:16:10Z | 2023-03649 | 0 | 0 | 090000648578b486 | |
| FDA-2019-N-0646-0002 | FDA | FDA-2019-N-0646 | Change of Address; Technical Amendment | Rule | Final Rule | 2023-03-02T05:00:00Z | 2023 | 3 | 2023-03-02T05:00:00Z | 2023-03-02T14:34:58Z | 2023-04010 | 0 | 0 | 090000648573e18d | |
| FDA-2023-N-0062-0001 | FDA | FDA-2023-N-0062 | Medical Devices; Hematology and Pathology Devices; Classification of the Software Algorithm Device To Assist Users in Digital Pathology | Rule | Final Rule | 2023-02-02T05:00:00Z | 2023 | 2 | 2023-02-02T05:00:00Z | 2023-02-02T14:40:06Z | 2023-02141 | 0 | 0 | 090000648562c147 | |
| FDA-2014-N-0053-1325 | FDA | FDA-2014-N-0053 | Requirements for Additional Traceability Records for Certain Foods - Correction | Rule | Correction | 2023-02-01T05:00:00Z | 2023 | 2 | 2023-02-01T05:00:00Z | 2023-09-26T14:20:06Z | C1-2022-24417 | 0 | 0 | 09000064856258ea | |
| FDA-2023-N-0091-0001 | FDA | FDA-2023-N-0091 | Medical Devices; Cardiovascular Devices; Classification of the Software for Optical Camera-Based Measurement of Pulse Rate, Heart Rate, Breathing Rate, and/or Respiratory Rate | Rule | Final Rule | 2023-01-31T05:00:00Z | 2023 | 1 | 2023-01-31T05:00:00Z | 2023-01-31T13:44:50Z | 2023-01967 | 0 | 0 | 090000648561eefa | |
| FDA-2017-C-6238-0017 | FDA | FDA-2017-C-6238 | Listing of Color Additives Exempt From Certification; Calcium Carbonate; Confirmation of Effective Date | Rule | Confirmation of Effective Date | 2023-01-24T05:00:00Z | 2023 | 1 | 2023-01-24T05:00:00Z | 2023-01-24T17:02:47Z | 2023-01185 | 0 | 0 | 0900006485606020 | |
| FDA-2011-N-0583-0016 | FDA | FDA-2011-N-0583 | Clarification of Orphan-Drug Exclusivity Following Catalyst Pharms., Inc. v. Becerra; Notification | Rule | Approval | 2023-01-24T05:00:00Z | 2023 | 1 | 2023-01-24T05:00:00Z | 2023-01-24T17:14:45Z | 2023-01179 | 0 | 0 | 0900006485606066 | |
| FDA-2022-N-3255-0001 | FDA | FDA-2022-N-3255 | Medical Devices; Gastroenterology-Urology Devices; Classification of the Computerized Behavioral Therapy Device for Treating Symptoms of Gastrointestinal Conditions | Rule | Final Rule | 2023-01-20T05:00:00Z | 2023 | 1 | 2023-01-20T05:00:00Z | 2023-01-20T16:22:34Z | 2023-01048 | 0 | 0 | 09000064855fbdb3 | |
| FDA-2018-N-3303-0022 | FDA | FDA-2018-N-3303 | Radiological Health Regulations; Amendments to Records and Reports for Radiation Emitting Electronic Products; Amendments to Performance Standards for Diagnostic X-ray, Laser, and Ultrasonic Products | Rule | Final Rule | 2023-01-20T05:00:00Z | 2023 | 1 | 2023-01-20T05:00:00Z | 2023-05-04T16:31:12Z | 2023-00922 | 0 | 0 | 09000064855fb48e | |
| FDA-2022-N-3256-0001 | FDA | FDA-2022-N-3256 | Medical Devices; Ophthalmic Devices; Classification of the Intense Pulsed Light Device for Managing Dry Eye | Rule | Final Rule | 2023-01-20T05:00:00Z | 2023 | 1 | 2023-01-20T05:00:00Z | 2023-01-20T14:52:23Z | 2023-01049 | 0 | 0 | 09000064855fbd7e | |
| FDA-2022-N-3335-0001 | FDA | FDA-2022-N-3335 | Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Prognostic Test for Assessment of Liver Related Disease Progression | Rule | Final Rule | 2023-01-17T05:00:00Z | 2023 | 1 | 2023-01-17T05:00:00Z | 2023-01-17T13:45:34Z | 2023-00480 | 0 | 0 | 09000064855f0e08 | |
| FDA-2022-N-3240-0001 | FDA | FDA-2022-N-3240 | Medical Devices; Neurological Devices; Classification of the Digital Therapy Device To Reduce Sleep Disturbance for Psychiatric Conditions | Rule | Final Rule | 2023-01-13T05:00:00Z | 2023 | 1 | 2023-01-13T05:00:00Z | 2023-01-13T13:20:40Z | 2023-00497 | 0 | 0 | 09000064855eba3f | |
| FDA-2022-N-3171-0001 | FDA | FDA-2022-N-3171 | Medical Devices; Ear, Nose, and Throat Devices; Classification of the Powered Insertion System for a Cochlear Implant Electrode Array | Rule | Final Rule | 2023-01-06T05:00:00Z | 2023 | 1 | 2023-01-06T05:00:00Z | 2023-01-06T13:29:39Z | 2023-00008 | 0 | 0 | 090000648559b1a3 | |
| FDA-2022-N-3189-0001 | FDA | FDA-2022-N-3189 | Medical Devices; Cardiovascular Devices; Classification of the Hardware and Software for Optical Camera-Based Measurement of Pulse Rate, Heart Rate, Breathing Rate, and/ or Respiratory Rate | Rule | Final Rule | 2023-01-06T05:00:00Z | 2023 | 1 | 2023-01-06T05:00:00Z | 2023-01-06T14:21:43Z | 2023-00010 | 0 | 0 | 090000648559b260 | |
| FDA-2022-N-3131-0001 | FDA | FDA-2022-N-3131 | Medical Devices; Physical Medicine Devices; Classification of the Electroencephalography-Driven Upper Extremity Powered Exerciser | Rule | Final Rule | 2023-01-06T05:00:00Z | 2023 | 1 | 2023-01-06T05:00:00Z | 2023-01-06T14:27:43Z | 2023-00007 | 0 | 0 | 090000648559b2a5 | |
| FDA-2022-N-3190-0001 | FDA | FDA-2022-N-3190 | Medical Devices; Orthopedic Devices; Classification of the Resorbable Shoulder Spacer | Rule | Final Rule | 2023-01-06T05:00:00Z | 2023 | 1 | 2023-01-06T05:00:00Z | 2023-01-06T14:16:33Z | 2023-00012 | 0 | 0 | 090000648559b25e | |
| FDA-2022-N-3184-0001 | FDA | FDA-2022-N-3184 | Medical Devices; Physical Medicine Devices; Classification of the Virtual Reality Behavioral Therapy Device for Pain Relief | Rule | Final Rule | 2023-01-06T05:00:00Z | 2023 | 1 | 2023-01-06T05:00:00Z | 2023-01-06T14:33:20Z | 2023-00014 | 0 | 0 | 090000648559b338 | |
| FDA-2022-N-3224-0001 | FDA | FDA-2022-N-3224 | Medical Devices; Neurological Devices; Classification of the Brain Stimulation Programming Planning Software | Rule | Final Rule | 2023-01-05T05:00:00Z | 2023 | 1 | 2023-01-05T05:00:00Z | 2023-01-05T14:44:22Z | 2022-28603 | 0 | 0 | 090000648558aa21 | |
| FDA-2019-F-3519-0002 | FDA | FDA-2019-F-3519 | Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D3 | Rule | Final Rule with Request for Comments | 2023-01-05T05:00:00Z | 2023 | 1 | 2023-01-05T05:00:00Z | 2023-02-07T04:59:59Z | 2023-02-07T02:00:23Z | 2022-28428 | 0 | 0 | 090000648558a92f |
| FDA-2022-N-3239-0001 | FDA | FDA-2022-N-3239 | Medical Devices; Orthopedic Devices; Classification of the Implantable Post- Surgical Kinematic Measurement Knee Device | Rule | Final Rule | 2023-01-05T05:00:00Z | 2023 | 1 | 2023-01-05T05:00:00Z | 2023-01-05T14:47:58Z | 2022-28604 | 0 | 0 | 090000648558a9d9 | |
| FDA-2022-N-3191-0001 | FDA | FDA-2022-N-3191 | Medical Devices; Orthopedic Devices; Classification of the Bone Indentation Device | Rule | Final Rule | 2023-01-05T05:00:00Z | 2023 | 1 | 2023-01-05T05:00:00Z | 2023-01-05T14:44:02Z | 2022-28601 | 0 | 0 | 090000648558aa1e | |
| FDA-2000-N-0011-0025 | FDA | Uniform Compliance Date for Food Labeling Regulations FDA-2000-N-0011 | Uniform Compliance Date for Food Labeling Regulations | Rule | Final Rule | 2023-01-03T05:00:00Z | 2023 | 1 | 2023-01-03T05:00:00Z | 2023-03-07T04:59:59Z | 2023-03-07T02:01:12Z | 2022-27902 | 0 | 0 | 090000648557e81d |
| FDA-2022-N-3207-0001 | FDA | FDA-2022-N-3207 | Medical Devices; Gastroenterology-Urology Devices; Classification of the Gastrointestinal Lesion SoftwareDetection System | Rule | Direct Final Rule | 2023-01-03T05:00:00Z | 2023 | 1 | 2023-01-03T05:00:00Z | 2023-01-04T15:40:56Z | 2022-28494 | 0 | 0 | 090000648557e719 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);